Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q3 Loss of $0.96
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.73 -0.44%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.96), versus ($0.68) reported last year. Revenue for the quarter came in at $15.8 million, versus $32.4 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Morgan Stanley sees quality stocks and AI adopters leading market
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
